Evidence map›Paper›PMID 31275453›Full record

ReviewDisease markers2019

Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction.

Mihaela Mocan, Larisa Diana Mocan Hognogi, Florin Petru Anton, Roxana Mihaela Chiorescu, Cerasela Mihaela Goidescu, Mirela Anca Stoia, Anca Daniela Farcas

Open access · hybridAbstract readReview
In one paragraph

Review in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mihaela Mocan"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.ORCID 0000-0001-5906-8024
Larisa Diana Mocan Hognogi"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.ORCID 0000-0001-6311-5890
Florin Petru Anton"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.ORCID 0000-0003-3753-0024
Roxana Mihaela Chiorescu"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.
Cerasela Mihaela Goidescu"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.ORCID 0000-0002-1488-8130
Mirela Anca Stoia"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.
Anca Daniela Farcas"Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania.ORCID 0000-0002-9407-2261
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular diastolic dysfunction (LVDD) is an important precursor to many different cardiovascular diseases. Diastolic abnormalities have been studied extensively in the past decade, and it has been confirmed that one of the mechanisms leading to heart failure is a chronic, low-grade inflammatory reaction. The triggers are classical cardiovascular risk factors, grouped under the name of metabolic syndrome (MetS), or other systemic diseases that have an inflammatory substrate such as chronic obstructive pulmonary disease. The triggers could induce myocardial apoptosis and reduce ventricular wall compliance through the release of cytokines by multiple pathways such as (1) immune reaction, (2) prolonged cell hypoxemia, or (3) excessive activation of neuroendocrine and autonomic nerve function disorder. The systemic proinflammatory state causes coronary microvascular endothelial inflammation which reduces nitric oxide bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG) activity in adjacent cardiomyocytes favoring hypertrophy development and increases resting tension. So far, it has been found that inflammatory cytokines associated with the heart failure mechanism include TNF-

Indexed as

BiomarkersCytokinesHumansInflammationMyocytes, CardiacVentricular Dysfunction, LeftBiomarkersCytokines

Identifiers

PMID31275453
PMCPMC6589287
OpenAlexW2947413215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.